Zevra Therapeutics Inc
F:1GDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zevra Therapeutics Inc
F:1GDA
|
US |
|
Tenaris SA
NYSE:TS
|
LU |
|
C
|
China Life Insurance Co Ltd
F:CHL
|
CN |
|
S
|
Sanofi SA
BMV:SNYN
|
FR |
|
Microstrategy Inc
NASDAQ:MSTR
|
US |
|
G
|
Granite Construction Inc
F:GRG
|
US |
|
CapitaLand Ascott Trust
OTC:ATTRF
|
SG |
|
B
|
Brunello Cucinelli SpA
F:8BU
|
IT |
|
L
|
Lands End Inc
SWB:LED
|
US |
|
O
|
Olin Corp
F:OLN
|
US |
|
B
|
Beiersdorf AG
F:BEI
|
DE |
|
Strongpoint ASA
F:PGT
|
NO |
|
E
|
Eni SpA
DUS:ENI
|
IT |
|
C
|
Cerner Corp
XBER:CRE
|
US |
|
Vita Coco Company Inc
NASDAQ:COCO
|
US |
|
P
|
PTC Inc
XMUN:PMTA
|
US |
|
R
|
RTL Group SA
XMUN:RRTL
|
LU |
|
A
|
Alphabet Inc
SWB:ABEA
|
US |
|
J
|
JCDecaux SA
F:DCS
|
FR |
|
Avista Corp
NYSE:AVA
|
US |
|
Hong Kong and China Gas Co Ltd
F:HCG
|
HK |
|
A
|
AES Corp
SWB:AES
|
US |
|
B
|
Biogen Inc
XMUN:IDP
|
US |
Bankruptcy Probability
Zevra Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Zevra Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
Z
|
Zevra Therapeutics Inc
NASDAQ:ZVRA
|
605.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
963.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
553.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
227.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
210.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Zevra Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Zevra Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
